ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
Dow Jones
44,296.51
0.97%
US Dollar vs MXN
20.4285
0.00%
Brent Oil
74.65
0.00%
Bitcoin
98,566.93
-0.47%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Alchimie (ALCHI) Cotización

Alchimie

Alchimie (ALCHI)

EU
0.317
0.003
(0.96%)
Cerrado 23 Noviembre 10:30AM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
0.317
Postura de Compra
0.316
Postura de Venta
0.317
Volume Operado de la Acción
9,866
0.299 Rango del Día 0.327
0.26 Rango de 52 semanas 1.48
Capitalización de Mercado [m]
1.411M
Precio Anterior
0.314
Precio de Apertura
0.315
Hora
70
@
0.317
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
21,486
Acciones en circulación
4,451,322
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.76
Beneficio por acción (BPA)
-0.42
turnover
11.33M
Beneficio neto
-1.87M

Acerca de Alchimie

Sector
Radio, Tv Advertising Reps
Industria
Radio, Tv Advertising Reps
Sitio web
www.alchimie.com
Sede
Aubervilliers, Seine-saint-denis, Fra
Fundado
-
Alchimie is listed in the Radio, Tv Advertising Reps sector of the Euronext with ticker ALCHI. The last closing price for Alchimie was 0.31 €. Over the last year, Alchimie shares have traded in a share price range of 0.26 € to 1.48 €.

Alchimie currently has 4,451,322 shares in issue. The market capitalisation of Alchimie is 1.40 € million. Alchimie has a price to earnings ratio (PE ratio) of -0.76.

ALCHI Últimas noticias

Más noticias

Alchimie Releases Its 2024 Half Year Results

H1 2024 revenue of €4.2 million, in line with annual guidance close to €8 million Strong gross margin maintained at 71% H1 2024 EBITDA breakeven Solid cash position of €4.5 million as of June...

23 Octubre 2024
Business Wire

ALCHIMIE : Bilan semestriel S1 2024 du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont

Regulatory News: Au titre du contrat de liquidité confié par la société ALCHIMIE (Paris:ALCHI) à la Société de Bourse Gilbert Dupont, à la date du 28 juin 2024, les moyens suivants figuraient au...

02 Julio 2024
Business Wire

Alchimie annonce la mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 7 juin 2024 et rappelle les modalités de participation

Regulatory News: ALCHIMIE (FR0014000JX7 – ALCHI – Eligible PEA-PME), channel factory permettant aux marques, médias et entreprises de créer, concevoir et animer leurs propres chaînes de vidéo...

17 Mayo 2024
Business Wire

Alchimie Announces Its 2023 Annual Results

2023 revenues of €11.3 million, in line with the guidance Good gross margin level maintained at 61% Positive 2023 EBITDA Cash position of €5.3 million at December 31, 2023 Regulatory News:...

25 Abril 2024
Business Wire

Alchimie Announces Its 2023 Revenues

2023 revenues of €11.3 million, in line with the guidance announced in October Further diversification of the business mix with the launch of videowall and 42videobricks solutions Positive 2023...

31 Enero 2024
Business Wire

ALCHIMIE : Bilan semestriel S2 2023 du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont

Regulatory News: Au titre du contrat de liquidité confié par la société ALCHIMIE (Paris:ALCHI) à la Société de Bourse Gilbert Dupont, à la date du 29 décembre 2023, les moyens suivants figuraient...

11 Enero 2024
Business Wire

Alchimie Announces Its Financial Calendar for 2024 Fiscal Year

Regulatory News: ALCHIMIE (FR0014000JX7 - ALCHI - PEA-PME eligible), a unique channel factory enabling brands, media and companies to create, design and animate their own themed video channels...

09 Enero 2024
Business Wire
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.033-9.428571428570.350.3520.299165470.32247826DE
4-0.005-1.552795031060.3220.460.288348760.34838132DE
12-0.137-30.17621145370.4540.4680.288214860.37105193DE
26-0.257-44.77351916380.5740.6780.288249900.44285923DE
52-0.973-75.42635658911.291.480.26337890.59029627DE
156-6.043-95.01572327046.366.40.26141251.11844159DE
260-15.683-98.018751619.980.26118452.09525906DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MLAAHAmatheon Agri Holding NV
0.02 €
(100.00%)
5k
GNROGeNeuro SA
0.0768 €
(25.49%)
200
BIDSGascogne DS
0.005 €
(25.00%)
150.51k
ALSAFSAFE
0.11 €
(23.73%)
39.98k
ALKKOKKO International SA
0.112 €
(21.21%)
4.13M
ALIMOGroupimo
0.189 €
(-40.94%)
392
MLUMGUmalis Group
1.30 €
(-31.22%)
1.71k
MLNMAMiguet Et Associes
0.075 €
(-24.62%)
1.72k
MLSEQSequa Petroleum NV
0.008 €
(-20.00%)
23k
VACBSPierre & Vacances
0.05 €
(-15.25%)
35.99k
BCPBanco Comercial Portugues SA
0.4446 €
(-0.49%)
69.24M
ALNEVNeovacs
0.0002 €
(0.00%)
41.4M
ALCYBCybergun
0.0001 €
(0.00%)
30.32M
INGAING Groep NV
14.652 €
(-1.16%)
14.06M
ACACredit Agricole SA
13.05 €
(-1.66%)
8.06M

Discusión

Ver feed completo
Freddie bagholder Freddie bagholder 5 minutos hace
Let’s see if on Monday Scott talks about gses
FNMA
SupernovaComet76 SupernovaComet76 6 minutos hace
https://lacdmhowr.powerappsportals.us/forums/general-discussion/03afd689-87a9-ef11-b542-001dd8097a1a
StealthyArcher52 StealthyArcher52 6 minutos hace
https://lacdmhowr.powerappsportals.us/forums/general-discussion/b5f04c58-87a9-ef11-b542-001dd8097a1a
ThunderousDefender5 ThunderousDefender5 6 minutos hace
https://lacdmhowr.powerappsportals.us/forums/general-discussion/c8dad835-84a9-ef11-b542-001dd8097a1a
frrol frrol 6 minutos hace
He has written against patient over-treatment and philosophically leans "less is more" on drug approvals and prescriptions. I suspect he's not a fan of the risky first-generation Alzheimer MAB therapies. Regardless, he'll make little difference for us and others, he's not radical or nutty.
AVXL
Krombacher Krombacher 7 minutos hace
Yup, he also "said too much" and was cut off as soon as he compared ERHC to Cove Energy.

Krombacher
ERHE
cojoboy cojoboy 7 minutos hace
Yeah..right...that's what you said @ 5 million shares..??..lol🤑🤑🤑
RDAR
cojoboy cojoboy 9 minutos hace
TY..sometimes even I get tired listening to myself..???🤔🤔🤔
RDAR
cojoboy cojoboy 13 minutos hace
Shhhh...don't tell anyone...
RDAR
RuudSaltis RuudSaltis 17 minutos hace
I agree with the exception of one point! Lightwave’s PR marketing and communication is so much worse! Poor press releases, no communication at all, horrible Benzinga as our spreading video channel…. With some poor LinkedIn Pozo video’s… brrrrr ….please management kick out MZ. Absolutely useless and
LWLG
Guzzi62 Guzzi62 18 minutos hace
BO? You don't know that, but are just guessing, like the rest of us.

L.P. said franchise, I know, but that's like spurring interest for the big companies, and I am certain they're also thinking about a BO.

What is the best medicine? Well, expect from the few hardcore i
NWBO
TrendTrade2016 TrendTrade2016 21 minutos hace
VUZI EXPLOSION WIT A 2.23 MAGNET
VUZI
TrendTrade2016 TrendTrade2016 24 minutos hace
MONTHLY SAR FLIP
PDYN
cojoboy cojoboy 26 minutos hace
LMFAOO..And on que..when they have no legitimate PHIL arguement.they resort to personal attacks..what's funny is 100% of people laugh at "ones" posts..please provide links to back ones claims...we all eagerly await..???😂😂😂😂
PHIL
TrendTrade2016 TrendTrade2016 27 minutos hace
QSI 2.01 TRIGGER SENDS THIS TO 2.33
QSI
marcis marcis 32 minutos hace
This is why Wei Tien HOMU’s owner has been quiet.
The massive CCP asset collection from wealthy even abroad

I think we are near a collapse of the CCP 2025
IMO

https://youtu.be/2b0Walwhl-w?si=ftoonOEW5VAIrH7v
HOMU
tm3141 tm3141 37 minutos hace

keywords - private sector, real estate 
FNMA
rikkie rikkie 38 minutos hace
With inferior technology. 🤣
LWLG
Truthsocial Truthsocial 38 minutos hace
Between 2006 and 2019, 9 out of 10 FDA commissioners went on to work for the pharmaceutical companies they were in charge of regulating.

Approximately 65% of the FDA's drug review budget comes directly from the pharmaceutical industry.

Americans are the sickest people o
RDGL
RichieBoy RichieBoy 40 minutos hace
There's at least 150 IT companies in Barcelona.

Neither MTi or AFFU have ever disclosed who owns DIGIBRIKS. If they had there would be a link, moreover AI agents would be able to tell you that link. About as close as we got Jim Honan disclosed DIGIBRIKS was made by a software and ser
AFFU
TrendTrade2016 TrendTrade2016 48 minutos hace
BZFD THE BUZZ HAS STARTED..EXPLOSION TIME
BZFD
Mr79 Mr79 49 minutos hace
You should ask CNNA.
CNNA
TrendTrade2016 TrendTrade2016 56 minutos hace
WLDS POST SPLIT BOTTOM BEAST READY TO FLY
WLDS
trader53 trader53 57 minutos hace
WCVC - WEST COAST VENTURES GROUP CORP



https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
____________________________________________________


Nixon Restaurant Group:

Todd Levick
Vice President
WCVC

Su Consulta Reciente

EU
ALCHI
Alchimie
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados